Back to Results
First PageMeta Content



Application of Natural Resources to Drug Discovery in Eisai Research and Development of Eribulin mesylate Katsuya Tagami, Eisai Co., Ltd. Eribuin mesylate is a first-in class, non-taxane microtubule dynamics inhibitor th
Add to Reading List

Document Date: 2017-05-01 03:53:28


Open Document

File Size: 53,67 KB

Share Result on Facebook